Evidence mapPaperPMID 42199839Full record

ArticlePeerJ2026

Correlation between the triglyceride-glucose index and retinal vascular parameters in the fundus: a cross-sectional study.

Zhenyan Wu, Yu Xin, Xue Jiang, Saiguang Ling, Caixia Guo

Abstract read
In one paragraph

Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhenyan Wu *Affiliated Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Yu Xin *Affiliated Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Xue JiangAffiliated Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Saiguang LingEVision Technology (Beijing) Co. LTD, Beijing, China.
Caixia GuoAffiliated Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The triglyceride-glucose (TyG) index is a simple, cost-effective indicator of insulin resistance, strongly linked to cardiovascular/cerebrovascular risk. Advances in deep learning enable quantitative retinal microvascular analysis from non-invasive fundus photography. This study assessed correlations between retinal vascular characteristics and the TyG index to explore relationships between glucose-lipid metabolism and microvascular alterations. Methods: This cross-sectional study included 712 inpatients from Beijing Tongren Hospital Cardiovascular Center. Patients were stratified by TyG index quartiles (Q1-Q4). Retinal vascular parameters were automatically quantified from color fundus photographs (CFPs) using a deep learning segmentation model. Linear regression and subgroup analyses evaluated associations with TyG. Results: Significant intergroup differences existed in hypertension, diabetes, revascularization history, Gensini score, body mass index (BMI), fasting blood glucose (FBG), total cholesterol (TC), triglycerides (TG), low- density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and glycated hemoglobin (HbA1c) ( Conclusion: TyG levels negatively correlate with retinal FD, VD, and AVR, and positively correlate with MBVD and MVD. Significant interactions exist in individuals ≥ 65 years, where TyG correlates strongly with FD, VD, MBVD, and MVD.

Indexed as

Blood GlucoseRetinal VesselsTriglyceridesAgedCross-Sectional StudiesFemaleFundus OculiHumansInsulin ResistanceMaleMiddle AgedBlood GlucoseTriglyceridesFundusRetinalTriglyceride-glucoseVascular

Identifiers

PMID42199839
PMCPMC13200662

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.